Investigating the efficacy of an add-on acceptance and commitment inpatient therapy in gerontopsychiatric patients diagnosed with depression and chronic pain - a randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032239

Enrollment

100

Registered

2023-07-13

Start date

2023-10-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain F32.0 F32.1 F32.2 F33.0 F33.1 F33.2

Interventions

Group 1: Intervention group: Treatment as usual + ACT-based add-on therapy for depression and chronic pain. In addition to the treatment as usual (i.e., psychopharmacological therapy, individual psyc

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Depressive episode, currently mild, moderate or severe without psychotic symptoms Recurrent depressive episode, currently mild, moderate or severe without psychotic symptoms Fulfillment of the criteria of the questionnaire chronic pain Fluent in written and spoken German

Exclusion criteria

Exclusion criteria: Reduction of intelligence according to clinical impression Acute suicidality Acute danger to others Acute self-injury Acute psychotic symptoms Bipolar disorders (current or past episodes) Schizophrenic disorders (current or past episodes) Biological therapy methods: Electroconvulsive therapy (ECT) and esketamine treatment (Spravato). Suspicion of a dementia and/or brain organic disease

Design outcomes

Primary

Measure	Time frame
Depressive symptoms (self-assessment) (BDI-II) Depressive symptoms (Objective Rater) (GRID-HAMD) Pain acceptance: (CPAQ-D) 3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).	—

Secondary

Measure	Time frame
Pain intensity (BPI) Psychological flexibility (FAH-II) Health-related quality of life (SF-12) 3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).	—

Countries

Germany

Contacts

Public ContactSarah Maria Kuhlen

Christophsbad Akademie für Psychotherapie (C-AP), Klinikum Christophsbad, Forschungssektion für angewandte Psychotherapie und Psychiatrie

sarah.kuhlen@christophsbad.de+4971616018688

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026